A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults
Clinical trial NCT07526116 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07526116
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-07
- Primary completion
- 2027-05-27
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.